Stocktoria

Universe Pharmaceuticals INC UPC

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-03-23

Universe Pharmaceuticals INC statistics & valuation

Market cap$1.9M
P / S0.0×
P / B0.0×
Net margin-20.6%
Return on equity-6.5%
FCF margin-29.8%
Return on capital-5.2%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
24.60% 23.60% -19.70% -20.40% -37.90% -20.60% 202020212022202320242025
Gross margin (%)
45.90% 52.80% 54.50% 31.90% 26.40% 35.30% 202020212022202320242025
Operating margin (%)
33.40% 28.30% -17.50% -12.30% -34.80% -16.30% 202020212022202320242025
Return on equity (%)
36.30% 24.10% 0.00% -23.50% -19.20% -6.50% 202020212022202320242025
Shares outstanding
16.0M 21.8M 21.8M 3.6M 23.6M 563338 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
26.20% 16.10% -13.30% -15772.60% -12.80% -5.30% 202020212022202320242025
Free cash flow margin (%)
19.70% -5.20% -3.50% 3.30% -42.20% -29.80% 202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
$0.47 $3.58 -$1309.11 -$1089.21 -$626.96 -$8.06 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Gross margin35.3%26.4%31.9%54.5%52.8%45.9%
Operating margin-16.3%-34.8%-12.3%-17.5%28.3%33.4%
Net margin-20.6%-37.9%-20.4%-19.7%23.6%24.6%
FCF margin-29.8%-42.2%3.3%-3.5%-5.2%19.7%
Return on assets-5.3%-12.8%-15772.6%-13.3%16.1%26.2%
Return on equity-6.5%-19.2%-23.5%-0.0%24.1%36.3%
Current ratio4.072.541.843.174.502.91

Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.